Vinorelbine and Docetaxel Combination as the First Line Treatment in Patients with Metastatic Breast Cancer: Results of a Multi-centric Phase II Trial in Iran
| Author | Ahamad Ameri | en |
| Author | Behrouz Shahrad | en |
| Author | Abollah Fazlalizadeh | en |
| Author | Hossein Madani | en |
| Author | Ahmad Mousavizadeh | en |
| Author | Shiva Moghadam | en |
| Issued Date | 2013-09-01 | en |
| Abstract | Introduction: We conducted a multi-centric phase II study to evaluate the tumor response and safety of the combination of vinorelbin and docetaxel in treatment of metastatic breast cancer patients. | en |
| DOI | https://doi.org/ | en |
| Keyword | Metastatic breast cancer | en |
| Keyword | chemotherapy | en |
| Keyword | vinorelbine | en |
| Keyword | docetaxel | en |
| Publisher | Brieflands | en |
| Title | Vinorelbine and Docetaxel Combination as the First Line Treatment in Patients with Metastatic Breast Cancer: Results of a Multi-centric Phase II Trial in Iran | en |
| Type | Research Article | en |